Iambic Therapeutics
SAN DIEGO, CA · Biotechnology · 119 employees
Iambic is a clinical-stage life-science and technology company developing novel medicines using its AI-driven discovery and development platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug candidates to human clinical trials with unprecedent
Funding history
- Venture - Series Unknown — $27.8M — Apr 2026
- Venture - Series Unknown — $99.3M — Nov 2025
- Funding Round — $100.0M — Nov 2025
- Venture - Series Unknown — $38.4M — Jun 2024
- Venture - Series Unknown — $29.9M — May 2024
Recent signals
- Apr 08, 2026: Raised $27.8M in Venture - Series Unknown
- Nov 21, 2025: Raised $99.3M in Venture - Series Unknown
- Nov 10, 2025: Raised $100.0M in Funding Round
- Jan 06, 2025: Iambic Therapeutics Appoints Michael Secora, Ph.D. as Chief Corporate Development Officer and Chief Financial Officer
- Oct 29, 2024: Launched Iambic Therapeutics Launches Enchant, an AI Platform to Predict Clinical Outcomes in Drug Discovery.
- Jun 06, 2024: Raised $38.4M in Venture - Series Unknown
- May 07, 2024: Raised $29.9M in Venture - Series Unknown
- Apr 25, 2024: Raised $26.9M in Venture - Series Unknown
See plans & pricing → Track Iambic Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.